4.7 Article

New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 151, 期 -, 页码 705-722

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.03.073

关键词

1, 2, 4-Triazole; Chalcone; Caspase-3; Apoptosis; A549 human lung; NCI

向作者/读者索取更多资源

A series of novel 1, 2, 4-triazole/ichalcone hybrids was prepared and identified with different spectroscopic techniques. The prepared compounds showed remarkable cytotoxic activity against different cancer cell lines. Compounds 24, 25, 27, 41 and 47 had shown the highest cytotoxicity among the tested compounds against human lung adenocarcinoma A549 cells with IC50 ranging from 4.4 to 16.04 mu M compared to cisplatin with IC50 of 153 mu M. Flow cytometric analysis of the tested compounds showed an increase in the number of apoptotic cells in a dose-dependent manner. The further mechanistic study demonstrated that 1, 2, 4-triazole-chalcone hybrids induced apoptosis via increased level of proapoptotic protein Bax, release of cytochrome c from mitochondria and activation of caspase-3/8/9 proteins. However, general caspase inhibition by the pan-caspase inhibitor, z-VAD-fmk, significantly decreased the apoptosis induced by the tested hybrids, suggesting dependency of apoptosis on activation of the caspase-3 pathway. (C) 2018 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids

Hossameldin A. Aziz, Gamal A. I. Moustafa, Gamal El-Din A. Abuo-Rahma, Safwat M. Rabea, Glenn Hauk, Vagolu S. Krishna, Dharmarajan Sriram, James M. Berger, Samar H. Abbas

Summary: A new series of nitric oxide-donating fluoroquinolone/oximes were synthesized, showing higher activity in antitubercular and antibacterial evaluations. Mycobacterial DNA cleavage and molecular modeling were used to explain the bioactivity observed. Oximes3c-e were highly potent against Klebsiella pneumoniae, while ketone2c and oxime4c were more active against Staphylococcus aureus than ciprofloxacin.

ARCHIV DER PHARMAZIE (2021)

Article Biochemistry & Molecular Biology

Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis

Hamada H. H. Mohammed, Samar H. Abbas, Alaa M. Hayallah, Gamal El-Din A. Abuo-Rahma, Yaser A. Mostafa

Summary: A novel series of urea-linked ciprofloxacin-chalcone hybrids 3a-j showed significant antiproliferative activities against colon cancer and leukemia cells, making them potential candidates for further optimization as antitumor agents.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases

Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, Ahmed M. Gouda, Bahaa G. M. Youssif, Hiroshi Tateishi, Mikako Fujita, Masami Otsuka, Mohamed Abdel-Aziz

Summary: A series of new quinoline/chalcone hybrids containing 1,2,4-triazole moiety were designed and synthesized in this study, showing moderate to good activity against various cancer cell lines. Some of these compounds exhibited promising antiproliferative activities and displayed high binding affinities in inhibiting EGFR and BRAF(V600E) kinases.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton

Muhamad Mustafa, Gamal El-Din A. Abuo-Rahma, Amer Ali Abd El-Hafeez, Esam R. Ahmed, Dalia Abdelhamid, Pradipta Ghosh, Alaa M. Hayallah

Summary: Small molecule inhibitors of focal adhesion kinase have shown promising therapeutic potential in cancer treatment. Among the 1,2,4-triazole derivatives tested, compounds 3c and 3d demonstrated the strongest antiproliferative activity, with 3d being identified as a potent preclinical candidate for cancer treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Biochemistry & Molecular Biology

Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition

Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan, Dalia Abdelhamid, Gamal El-Din A. Abuo-Rahma

Summary: A new series of synthesized compounds showed high anticancer activity, with one dihalogenated derivative exhibiting the best cytotoxicity. Some compounds exhibited VEGFR-2 inhibitory activity similar to sorafenib, indicating potential antiproliferative effects.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization

Hamada H. H. Mohammed, Amer Ali Abd El-Hafeez, Kareem Ebeid, Aml Mekkawy, Mohammed A. S. Abourehab, Emad Wafa, Suhaila O. Alhaj-Suliman, Aliasger K. Salem, Pradipta Ghosh, Gamal El-Din A. Abuo-Rahma, Alaa M. Hayallah, Samar H. Abbas

Summary: The novel ciprofloxacin hybrids demonstrated remarkable anti-proliferative activity against colon cancer cells by inhibiting topoisomerase and tubulin polymerization, suggesting their potential as novel anticancer agents. Their mechanism of action involves DNA damage and cell cycle arrest through the ATR/CHK1/Cdc25C pathway.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors

Hamada H. H. Mohammed, Doaa Mohamed Elroby Ali, Mohamed Badr, Ahmed G. K. Habib, Abobakr Mohamed Mahmoud, Sarah M. Farhan, Shimaa Salah Hassan Abd El Gany, Soad A. Mohamad, Alaa M. Hayallah, Samar H. Abbas, Gamal El-Din A. Abuo-Rahma

Summary: A series of N-4 piperazinyl ciprofloxacin derivatives were synthesized and showed broad antibacterial and antifungal activities. Some of the derivatives also exhibited inhibitory activity against DNA gyrase.

MOLECULAR DIVERSITY (2023)

Article Chemistry, Medicinal

New 1,3,4-oxadiazole-chalcone/benzimidazole hybrids as potent antiproliferative agents

Fatma Fouad Hagar, Samar H. Abbas, Dalia Abdelhamid, Hesham A. M. Gomaa, Bahaa G. M. Youssif, Mohamed Abdel-Aziz

Summary: A series of new 1,3,4-oxadiazole-chalcone/benzimidazole hybrids were synthesized and investigated for their antiproliferative activities. Compounds 9g-i and their oxygen isosteres, 10f-h, exhibited promising antiproliferative activities with IC50 values ranging from 0.80 to 2.27 μM.

ARCHIV DER PHARMAZIE (2023)

Article Chemistry, Multidisciplinary

Design, synthesis, and biological investigation of quinoline/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents

Hend A. A. Ezelarab, Heba A. A. Hassan, Gamal El-Din A. Abuo-Rahma, Samar H. H. Abbas

Summary: A series of Ciprofloxacin-Piperazine C-7 linked quinoline derivatives were synthesized and evaluated for their antimicrobial, antifungal, and anti-proliferative activities. Compound 6a, 6b, and 8a demonstrated promising anticancer, antifungal, and antibacterial properties, indicating their potential as lead compounds for drug discovery.

JOURNAL OF THE IRANIAN CHEMICAL SOCIETY (2023)

Article Biochemistry & Molecular Biology

New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization

Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas, Ahmed M. Sayed, Eman A. M. Beshr, Heba A. Hassan

Summary: New 3-substituted oxindole derivatives were synthesized and evaluated as antiproliferative agents. Among the tested compounds, compounds 6f and 6g showed remarkable antiproliferative activity against leukemia and breast cancer cell lines. Compound 6f exhibited the most promising antiproliferative activity against MCF-7 (human breast cancer), and inhibited receptor tyrosine EGFR and tubulin polymerization.

MOLECULAR DIVERSITY (2023)

Review Chemistry, Medicinal

Harnessing pyrimidine as a building block for histone deacetylase inhibitors

Mostafa M. Badran, Samar H. Abbas, Mikako Fujita, Mohamed Abdel-Aziz

Summary: Histone deacetylase (HDAC) inhibitors, particularly those based on the pyrimidine scaffold, have shown great potential as bioactive agents against tumors and neurodegenerative disorders. In this article, we provide a comprehensive overview of the successful utilization of pyrimidine and its derivatives in the development of HDAC inhibitors. We also discuss the perspectives and strategies that may guide medicinal chemists in designing more effective chemotherapeutic agents with potential clinical applications in the future.

ARCHIV DER PHARMAZIE (2023)

Review Chemistry, Multidisciplinary

Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia

Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. H. Abbas, Heba A. A. Hassan, Eman A. M. Beshr

Summary: FLT3 mutations are common in AML patients and are associated with poor clinical response. Several FLT3 inhibitors have been developed, but the overall survival rate in AML patients is still low. This review summarizes the indole-based FLT3 inhibitors and their chemotypes, mechanism of action, and interaction mode. It provides insights for future exploration of new therapies for FLT3-related AML.

BMC CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E

Fatma Fouad Hagar, Samar H. Abbas, Hesham A. M. Gomaa, Bahaa G. M. Youssif, Ahmed M. Sayed, Dalia Abdelhamid, Mohamed Abdel-Aziz

Summary: This study successfully demonstrated the potential of new compounds in cancer treatment and induction of apoptosis. The compounds showed inhibitory effects on cell proliferation, EGFR, and BRAF(V600E), and induced apoptosis in cancer cells.

BMC CHEMISTRY (2023)

Review Chemistry, Multidisciplinary

Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review

Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, Hamdy M. Abdel-Rahman, Mohamed Abdel-Aziz

Summary: Lung cancer is the second most common cause of morbidity and mortality among cancer types worldwide, with non-small cell lung cancer (NSCLC) representing the majority of most cases. EGFR TKIs are widely used as targeted therapy for NSCLC, but their efficacy is compromised by acquired mutations, including C797S. The development of next-generation EGFR TKIs that selectively inhibit EGFR triple mutations is of urgent medical need. This review discusses the design of fourth-generation EGFR TKIs, their binding interactions, clinical difficulties, and potential outcomes of treating patients with C797S mutation.

RSC ADVANCES (2023)

Review Chemistry, Organic

SYNTHETIC APPROACHES TOWARD CERTAIN STRUCTURALLY RELATED ANTIMICROBIAL THIAZOLE DERIVATIVES (2010-2020)

Abdelfattah Hassan, Heba A. Hassan, Dalia Abdelhamid, Gamal El-Din A. Abuo-Rahma

Summary: In this literature review, various methods of synthesizing antimicrobial thiazole derivatives published in the past decade are comprehensively discussed, with a focus on those exhibiting antibacterial, antimycobacterial, and/or antifungal activity. The diversity of thiazole-derived antimicrobial agents is highlighted through categorization into chemical classes, showcasing the common methods of thiazole ring closure and the antimicrobial activity of the most potent derivatives.

HETEROCYCLES (2021)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)